ESCRS - PO316 - Allogeneic Fresh Frozen Plasma For The Treatment Of Ocular Gvhd: Prospective Phase 2 Open-Label Study

Allogeneic Fresh Frozen Plasma For The Treatment Of Ocular Gvhd: Prospective Phase 2 Open-Label Study

Published 2022 - 40th Congress of the ESCRS

Reference: PO316 | Type: Free paper | DOI: 10.82333/2xdj-cb69